<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
<channel>
                    <title>Urology</title>
            <link>https://medicalxpress.com/urology-news/</link>
            <language>en-us</language> 
            <description>Latest medical news and research in Urology</description>

                            <item>
                    <title>Aspirin may unmask silent bladder cancer by triggering bleeding</title>
                    <description>The presence of blood cells in urine is a sign of bladder cancer. Because aspirin blocks platelets from forming harmful blood clots, the medication can cause mild bleeding or worsen existing bleeding in the urinary tract. Results from a study in the Journal of Internal Medicine suggest that this may prompt a clinician to run tests to uncover an asymptomatic bladder tumor.</description>
                    <link>https://medicalxpress.com/news/2026-06-aspirin-unmask-silent-bladder-cancer.html</link>
                    <category></category>
                    <pubDate>Wed, 03 Jun 2026 03:10:01 EDT</pubDate>
                    <guid isPermaLink="false">news699611881</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2022/aspirin-pills.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Immunotherapy added to radiation therapy boosts survival in localized prostate cancer</title>
                    <description>Results of a multicenter clinical trial found that adding the investigational adenoviral-based viral immunotherapy aglatimagene besadenovec (alglatimagene, CAN-2409) to standard radiation therapy improved disease-free survival for patients with intermediate- or high-risk localized prostate cancer. The study was led by researchers at the Johns Hopkins University School of Medicine, Johns Hopkins Kimmel Cancer Center, Department of Radiation Oncology and Molecular Radiation Sciences, and Brady Urological Institute. Findings from the study were published June 1 in The Lancet Oncology.</description>
                    <link>https://medicalxpress.com/news/2026-06-immunotherapy-added-therapy-boosts-survival.html</link>
                    <category></category>
                    <pubDate>Tue, 02 Jun 2026 16:40:05 EDT</pubDate>
                    <guid isPermaLink="false">news699629521</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/radiation-therapy.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Novel prostate cancer treatment can reduce risk of disease progression by half, clinical trial shows</title>
                    <description>A Phase III clinical trial led by Neeraj Agarwal, MD, FASCO, senior director of clinical research at Huntsman Cancer Institute and professor of internal medicine at the University of Utah (the U), has found that a combination prostate cancer treatment could prevent the disease from progressing into a harder-to-treat form of cancer in select patients.</description>
                    <link>https://medicalxpress.com/news/2026-06-prostate-cancer-treatment-disease-clinical.html</link>
                    <category></category>
                    <pubDate>Tue, 02 Jun 2026 13:00:01 EDT</pubDate>
                    <guid isPermaLink="false">news699618781</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/prostate-cancer.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Cannabis use does not lower testosterone, study concludes</title>
                    <description>The effects of cannabis on the hormonal system and male fertility remain controversial within the scientific community. A study conducted by the University of Geneva (UNIGE), in collaboration with the Swiss Center for Applied Human Toxicology (SCAHT), provides a new answer by showing that cannabis use does not reduce testosterone levels in young men and may even increase its testicular synthesis.</description>
                    <link>https://medicalxpress.com/news/2026-05-cannabis-testosterone.html</link>
                    <category></category>
                    <pubDate>Thu, 28 May 2026 08:40:01 EDT</pubDate>
                    <guid isPermaLink="false">news699175982</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/cannabis-use.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>New marker identifies patients with advanced prostate cancer more likely to benefit from combination immunotherapy</title>
                    <description>Researchers with the James P. Allison Institute at The University of Texas MD Anderson Cancer Center have discovered a new gene expression signature within tumors that can help identify patients with metastatic castration-resistant prostate cancer (mCRPC) who are more likely to experience lasting benefits from combined immunotherapy treatment.</description>
                    <link>https://medicalxpress.com/news/2026-05-marker-patients-advanced-prostate-cancer.html</link>
                    <category></category>
                    <pubDate>Thu, 21 May 2026 09:20:03 EDT</pubDate>
                    <guid isPermaLink="false">news698572854</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2022/prostate-cancer.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Blood test spots failing prostate cancer treatment within 6-12 weeks, study finds</title>
                    <description>A new blood test could help doctors identify whether a treatment for advanced prostate cancer is failing weeks earlier than current tests, according to a U.K.-wide study led by UCL researchers. The study, published in Nature Cancer, shows that men could switch or intensify treatment much sooner than is currently possible if their cancer is not responding to treatment, potentially saving precious time and improving outcomes for patients.</description>
                    <link>https://medicalxpress.com/news/2026-05-blood-prostate-cancer-treatment-weeks.html</link>
                    <category></category>
                    <pubDate>Mon, 18 May 2026 16:00:05 EDT</pubDate>
                    <guid isPermaLink="false">news698335482</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/blood-test-flags-faili.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Viagra could hold key to halting Peyronie&#039;s disease</title>
                    <description>Combining two widely prescribed drug classes could provide the first effective treatment for early-stage Peyronie&#039;s disease, according to a new study published in The Journal of Sexual Medicine.</description>
                    <link>https://medicalxpress.com/news/2026-05-viagra-key-halting-peyronie-disease.html</link>
                    <category></category>
                    <pubDate>Thu, 14 May 2026 19:10:01 EDT</pubDate>
                    <guid isPermaLink="false">news697966741</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/man-job.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Experimental drug shrinks advanced kidney tumors, clears cancer in one patient</title>
                    <description>A new Phase I clinical trial provides proof of concept for a potential therapy for treatment-resistant cancers, particularly kidney cancer. In the new study, published in Cell Reports Medicine, researchers tested a novel kind of immunotherapy in individuals with different types of cancer.</description>
                    <link>https://medicalxpress.com/news/2026-05-experimental-drug-advanced-kidney-tumors.html</link>
                    <category></category>
                    <pubDate>Thu, 14 May 2026 13:00:01 EDT</pubDate>
                    <guid isPermaLink="false">news697982393</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/novel-drug-shows-promi.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Novel molecular marker may improve prostate cancer treatment</title>
                    <description>Most prostate cancers rely on male sex hormones, known as androgens, to grow. As a result, standard treatment focuses on lowering androgen levels or blocking their activity, but many tumors eventually become resistant and the disease returns.</description>
                    <link>https://medicalxpress.com/news/2026-05-molecular-marker-prostate-cancer-treatment.html</link>
                    <category></category>
                    <pubDate>Tue, 12 May 2026 15:20:04 EDT</pubDate>
                    <guid isPermaLink="false">news697814522</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/novel-molecular-marker-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Cranberry juice may boost UTI antibiotics</title>
                    <description>More than 400 million people experience a urinary tract infection every year, and some epidemiological studies estimate that more than half of all women will develop at least one in their lifetime. Most UTIs are caused by pathogenic strains of Escherichia coli bacteria, and the antibiotic fosfomycin is often prescribed as the first line of treatment. However, increasing resistance to antibiotics is driving a search for alternative approaches to treatment.</description>
                    <link>https://medicalxpress.com/news/2026-05-cranberry-juice-boost-uti-antibiotics.html</link>
                    <category></category>
                    <pubDate>Mon, 04 May 2026 09:00:05 EDT</pubDate>
                    <guid isPermaLink="false">news696852841</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/cranberry-juice.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Team targets the spinal cord to solve paralysis&#039; most overlooked problem</title>
                    <description>Approximately 308,000 people in the United States live with spinal cord injury. Nearly all lose bladder control. And yet the vast majority of research and engineering attention in neurotech has poured into motor restoration—making paralyzed limbs move again.</description>
                    <link>https://medicalxpress.com/news/2026-04-team-spinal-cord-paralysis-overlooked.html</link>
                    <category></category>
                    <pubDate>Thu, 30 Apr 2026 11:20:05 EDT</pubDate>
                    <guid isPermaLink="false">news696764238</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/team-targets-the-spina.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Tumor bacteria inspire peptide that starves prostate cancer cells in preclinical tests</title>
                    <description>Researchers at the University of Illinois Chicago have developed an anti-cancer therapy inspired by bacteria found in cancer tumors. When tested in combination with radiation in animal models of prostate cancer, it was highly effective—the approach effectively shut down tumor growth.</description>
                    <link>https://medicalxpress.com/news/2026-04-tumor-bacteria-peptide-starves-prostate.html</link>
                    <category></category>
                    <pubDate>Wed, 29 Apr 2026 08:00:01 EDT</pubDate>
                    <guid isPermaLink="false">news696666786</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/scientists-source-anti.jpg" width="90" height="90" />
                                    </item>
                    </channel>
</rss>
